UK markets closed

Lattice Biologics Ltd. (LBLTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 03:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.82k
Enterprise value -13.03k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.01
Price/book (mrq)N/A
Enterprise value/revenue -0.01
Enterprise value/EBITDA 0.06

Trading information

Stock price history

Beta (5Y monthly) -2.55
52-week change 30.00%
S&P500 52-week change 321.08%
52-week high 30.0001
52-week low 30.0000
50-day moving average 30.0001
200-day moving average 30.0001

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5128.22M
Implied shares outstanding 640.67B
Float 884.18M
% held by insiders 12.32%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:3
Last split date 304 Jan 2016

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2020
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin -61.08%
Operating margin (ttm)-39.52%

Management effectiveness

Return on assets (ttm)-24.95%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.56M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -264.73k
Net income avi to common (ttm)-951.65k
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)N/A
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-132.01k
Levered free cash flow (ttm)N/A